Use of sibutramine analogues to lower lipid levels
A compound of formula (I) or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3- methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for lowering lipid levels and/or i...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng ; slo |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A compound of formula (I) or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3- methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for lowering lipid levels and/or increasing the HDL : LDL cholesterol ratio in humans, for example in humans having hyperlipidaemia, hypercholesterolaemia or hypertriglyceridaemia.
Použitie sibutramínového analógu vzorca (I) alebo jeho farmaceuticky prijateľná soľ, kde R1 a R2 sú nezávisle H alebo metyl, napríklad N, N-dimetyl-1-[1-(4-chlórfenyl)cyklobutyl]-3- metylbutyl amín hydrochlorid voliteľne vo forme svojho monohydrátu, na prípravu liečiva na znižovanie hladín lipidov a/alebo na zvyšovanie pomeru HDL : LDL cholesterolu u ľudí s hyperlipidémiou, hypercholesterolémiou alebo hypertriglyceridémiou.ŕ |
---|